Healthcare >> CEO Interviews >> November 17, 2008
ARTHUR P. BOLLON, Chairman, President and CEO of HemoBioTech, Inc., since 2003,
brings 25 years' experience in biotechnology as a scientist, executive and
entrepreneur. He has been the. Founder, former Chairman and CEO of Wadley
Biosciences Inc., a joint venture between Wadley Cancer Center and Phillips
Petroleum. He is the Founder, former Chairman and CEO of Cytoclonal
Pharmaceutics, led an IPO in 1995 and closed a licensing agreement with Bristol
Meyers Squibb. Dr. Bollon holds a PhD in Molecular Genetics from Rutgers
University and was a Post Doctoral Fellow at Yale University. Profile
Dr. Bollon: HemoBioTech is a biotechnology company with headquarters in Dallas
and production and development at Texas Tech
